Literature DB >> 7522364

Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.

D K Bishop1, W Li, S Y Chan, R D Ensley, J Shelby, E J Eichwald.   

Abstract

Initial treatment of heterotopic cardiac transplant recipients with anti-CD4 mAb promotes long-term (> 60 days) allograft survival. We have used modified limiting dilution analysis to quantitate donor alloantigen-reactive helper T lymphocytes (HTL) and CTL in mice bearing long-term cardiac allografts. Despite repopulation of lymphoid tissues with CD4+ T cells, donor alloantigen-reactive IL-2 producing and IL-4-producing HTL were rare or not detectable in lymphoid tissues or in the graft. While donor-reactive precursor CTL were present in lymphoid tissues, modified limiting dilution analysis revealed that stimulated ("antigen-conditioned") CTL were not detectable, and few CTL were present in the graft. In addition, antibodies reactive with donor alloantigens were not detectable in the sera of mice bearing long-term cardiac allografts. To determine whether additional in vivo stimulation with donor alloantigens would elicit an immune response, sponge allografts were implanted into mice bearing long-term cardiac allografts. Previous reports from this laboratory have demonstrated that T cell infiltration of sponge allografts is dependent upon antigen-driven cytokine production. While third-party sponge allografts were readily infiltrated by third-party-reactive HTL and CTL, sponge allografts of the same strain as the cardiac allograft were not infiltrated by T cells. However, donor strain sponge allografts induced an IgM (but not IgG) alloantibody response. These data indicate that IgM alloantibody could be induced in the absence of a cellular response to the sponge allograft. Kinetic studies revealed that a transient IgM (but not IgG) response was induced by the initial cardiac transplantation in the absence of CD4+ cells. These IgM alloantibodies disappeared by day 21 despite the persistence of the allograft. These observations indicate that transient depletion of CD4+ T cells induces allograft-specific T cell tolerance, but does not eliminate the ability to mount an allograft-specific IgM response. To our knowledge, this is the first report of a transient humoral response to alloantigens that occurs in the absence of CD4+ T cells, and can be reinduced in "tolerant" animals that fail to mount a cellular immune response. Potential mechanisms involved in the development and maintenance of anti-CD4 mAb-induced tolerance are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522364     DOI: 10.1097/00007890-199409150-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

Authors:  K Csencsits; B E Burrell; G Lu; E J Eichwald; G L Stahl; D K Bishop
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

2.  Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.

Authors:  Sherri Wood; Jiane Feng; Jooho Chung; Vedran Radojcic; Ashley R Sandy-Sloat; Ann Friedman; Amy Shelton; Minhong Yan; Christian W Siebel; D Keith Bishop; Ivan Maillard
Journal:  J Immunol       Date:  2015-02-16       Impact factor: 5.422

3.  Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.

Authors:  Adam J Booth; Sherri C Wood; Ashley M Cornett; Alyssa A Dreffs; Guanyi Lu; Andrés F Muro; Eric S White; D Keith Bishop
Journal:  J Pathol       Date:  2012-01-04       Impact factor: 7.996

4.  IL-6 promotes cardiac graft rejection mediated by CD4+ cells.

Authors:  Adam Jared Booth; Svetlana Grabauskiene; Sherri Chan Wood; Guanyi Lu; Bryna E Burrell; D Keith Bishop
Journal:  J Immunol       Date:  2011-10-24       Impact factor: 5.422

5.  Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells.

Authors:  S C Wood; G Lu; B E Burrell; D K Bishop
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086

6.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

7.  Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.

Authors:  J A Diaz; A J Booth; G Lu; S C Wood; D J Pinsky; D K Bishop
Journal:  Am J Transplant       Date:  2009-06-16       Impact factor: 8.086

8.  OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.

Authors:  Bryna E Burrell; Guanyi Lu; Xian C Li; D Keith Bishop
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Bernard L Marini; Weiping Zou; David Gordon; Yoichiro Iwakura; Yasmina Laouar; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

10.  TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Sherri C Wood; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.